Long-term data confirms bladder cancer therapy provides lasting benefits for patients.

Breakthrough brain cancer therapy research presented at international congress advances treatment options.

Celcuity's first FDA-approved breast cancer drug provides patients with an innovative new treatment option.

Merck's Keytruda achieves key clinical trial success, advancing immunotherapy options for cancer patients.

Promising breast cancer treatment receives FDA approval pathway consideration.

A major pancreatic cancer breakthrough is generating excitement among medical experts and offering renewed optimism.

Breakthrough lung transplant research offers new hope to lung cancer patients.

Scientists achieve a major breakthrough in treating previously undruggable lung cancer.

Scientists identify new cellular structures that could revolutionize cancer research and treatment approaches.

Market predictions show strong confidence in an upcoming AML drug trial success with 83% odds of positive results.

FDA approves first-of-its-kind Treg cell therapy offering new hope for blood cancer transplant patients.

Scientists discover a method to halt cancer drug resistance early, potentially extending the effectiveness of cancer treatments.

A successful clinical trial offers new hope and treatment options for Hodgkin lymphoma patients.

China's approval of the first solid tumor CAR-T therapy represents significant progress in cancer treatment.

Veppanu (vepdegestrant) receives FDA approval, offering breast cancer patients a new hormonal treatment option.

GLP-1 medications shown to reduce cancer risk, earning researcher recognition for this significant discovery.

FDA grants full approval for engineered cell therapy with expanded indication, helping more patients with blood cancers.

A single blood test screening for multiple cancer types may soon become available, potentially revolutionizing early cancer detection.

An experimental prostate cancer treatment successfully eliminates tumor cells while restoring the body's natural immune response.

GSK's acquisition of advanced lung cancer drugs brings promising new treatments closer to patients.

Hundreds of UK women will benefit from a breakthrough ovarian cancer treatment offering new hope.

Daraxonrasib represents a significant new treatment option that could improve outcomes for pancreatic cancer patients.

New bladder cancer drug helps individual patient achieve improved outcomes and quality of life.

A vitamin D analog from Salk Institute successfully disarms pancreatic cancer's defenses in clinical trials, moving from lab to patient treatment.

FDA approval of new ovarian cancer treatments expands therapeutic options for patients.

Datroway received FDA approval as the first TROP2-directed antibody drug for metastatic triple-negative breast cancer treatment.

New understanding of how cancer develops during cell division could lead to improved prevention strategies.

FDA approvals of Beqalzi and Inqovi represent important new treatment options for patients with mantle cell lymphoma and blood cancers.

BeOne receives FDA approval for a new mantle cell lymphoma therapy, establishing an entirely new class of treatment options for patients.

A new medical breakthrough offers hope in the fight against cancer detection and treatment.

Kelun-Biotech's innovative PD-1 x VEGF bispecific antibody receives investigational approval for cancer treatment.

A pancreatic cancer patient is finding renewed hope through breakthrough treatments that are extending and improving her life.

Researchers have unveiled a groundbreaking single-shot treatment with potential to end breast cancer.

Scientists harness cancer's own bacteria to fight the disease in a groundbreaking therapeutic approach.

Yale-developed technology receives FDA approval, offering new hope for breast cancer patients.

Mayo Clinic achieves breakthrough in early cancer detection, potentially saving lives through earlier intervention.

Actor Sam Neill celebrates cancer-free status after successful CAR-T cell therapy clinical trial.

A researcher receives significant funding to advance a breakthrough breast cancer treatment that could help countless patients.

A groundbreaking immunotherapy achieves a perfect success rate against a specific type of bowel cancer.

Scientists develop a promising breakthrough drug targeting KRAS mutations in pancreatic cancer, offering hope for patients with this deadly disease.

Novel approach to pancreatic cancer treatment offers unconventional hope through innovative targeting strategies.

PDS Biotech's colorectal cancer treatment shows promising trial results, offering hope for improved patient outcomes.

UT MD Anderson shares exciting new cancer research breakthroughs at major conference.

Revolution Medicines' late-stage trial success brings potential breakthrough pancreatic cancer treatment closer to patients.

Multiple new oncology drugs received FDA approval, expanding treatment options for cancer patients.

FDA approves new cancer drug for trials using innovative nonanimal data, marking progress in both treatment and ethical research.

A cancer treatment demonstrates unexpected benefits beyond initial scientific predictions.

Researchers have achieved promising results with a potential new treatment for the deadly brain cancer glioblastoma.

A symposium showcases significant progress in gastrointestinal cancer treatment options and research initiatives.

International trial launches to develop better cancer treatments specifically for young people.

Dual treatment breakthrough addresses both lung cancer and muscle loss, improving quality of life for patients.

New discovery in eye cancer treatment offers patients additional therapeutic options.

A strategic partnership between ABK Biomedical and MURR aims to advance a groundbreaking cancer therapy toward clinical use.

Identification of pancreatic cancer's vulnerability opens promising new avenues for developing more effective treatments.

A fundraiser raised $3.5M to support breakthrough cancer research that could transform patient outcomes.

NTU team reports promising cancer research breakthrough spanning early detection to targeted therapy.

Memorial Sloan Kettering's new colorectal cancer treatments aim to significantly reduce mortality rates in the coming years.

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation, offering new hope for patients.

Cancer trial in Shropshire significantly improves survival outcomes for men with the disease.